Both the use of next-generation sequencing (NGS) testing for cancer and the rate of claim denials for such testing increased between 2016 and 2021, despite implementation of a recent Medicare national coverage determination that established coverage standards for NGS testing...
55W 14th St Ste 101, Helena, Montana, 59601, US
+1(406)-319-1601
news.in.usa@olahost.top
Copyright © 2024 olascience. All Rights Reserved